SCHEMBL6203321

SCHEMBL6203321

CCCc1cc(OC)c2cc(C(=O)OCC)ccc2n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 1/20 0.51
ALDH1A1 P00352 5/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
NPC1 O15118 5/20 0.49
RAB9A P51151 5/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
KDM4E B2RXH2 3/20 0.48
HPGD P15428 2/20 0.48
HSD17B10 Q99714 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
MCHR1 Q99705 1/20 0.47
PDGFRB P09619 1/20 0.46
PDGFRA P16234 1/20 0.46
TP53 P04637 3/20 0.46
MAPT P10636 3/20 0.46
STAT1 P42224 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204138 0.87 MCHR1 (0.50) ALDH1A1NPC1RAB9AKDM4EMCHR1
SCHEMBL6201906 0.85 ALDH1A1 (0.53) HSD17B2ALDH1A1L3MBTL1NPC1RAB9A
SCHEMBL6221754 0.78 RECQL (0.47) NPC1RAB9AKDM4EHSD17B10SMN1; SMN2
SCHEMBL6221751 0.78 MCHR1 (0.47) ALDH1A1KDM4EHPGDSMN1; SMN2MCHR1
SCHEMBL4259484 0.76 MCHR1 (0.62) ALDH1A1NPC1RAB9AKDM4EHPGD
SCHEMBL9907539 0.76 ALDH1A1 (0.60) ALDH1A1L3MBTL1NPC1RAB9ACYP1A2
SCHEMBL9909163 0.74 ALDH1A1 (0.52) ALDH1A1L3MBTL1NPC1RAB9ACYP1A2
SCHEMBL9709715 0.73 ALDH1A1 (0.57) ALDH1A1L3MBTL1NPC1RAB9ACYP1A2
Chimanine A SCHEMBL8588818 0.73 HPGD (0.59) ALDH1A1KDM4EHPGDSMN1; SMN2MAPT
SCHEMBL9907605 0.72 ALDH1A1 (0.66) ALDH1A1L3MBTL1NPC1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451156-A4 4-AMINOQUINOLINE COMPOUNDS MERCK & CO INC (US) 2005-05-25 EP disclosed
US-20050009815-A1 4-Aminoquinoline compounds DEVITA ROBERT J (US) 2005-01-13 US disclosed
EP-1451156-A1 4-AMINOQUINOLINE COMPOUNDS Merck & Co., Inc. (US) 2004-09-01 EP disclosed
WO-2003045920-A1 4-AMINOQUINOLINE COMPOUNDS MERCK & CO., INC. (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009815-A1 4-Aminoquinoline compounds MCHR1, MCHR2, MC5R HSD17B2 443/4885ALDH1A1 364/4885L3MBTL1 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.